CDIO

Cardio Diagnostics Holdings, Inc. (CDIO) | Rumor.io

Cardio Diagnostics Holdings

CDIO

Attention (50-day avg)0%

Attention rank (50-day avg)#3,335

Bullish sentiment (50-day avg)100%

Price to earnings ratio-0.5

Market capitalization5.6M

Earnings per share-2.9

Dividend yield (TTM)—

Revenue (annual)14.8K

Net income (annual)-6.5M

Social

What share of all stock conversation is about CDIO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% -0.01

Jul 16

Cardio Diagnostics Holdings, Inc. (CDIO) is positioned at the intersection of AI and precision medicine, potentially offering significant opportunities in the healthcare sector.
CDIO's focus on AI and precision medicine may enable it to improve healthcare outcomes, making it an attractive investment for those interested in the intersection of technology and healthcare.
The company's unique approach to combining AI with precision medicine could lead to breakthroughs in medical diagnosis and treatment, driving growth and innovation in the healthcare industry.

Generated by AI

Sentiment

Of the messages about CDIO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% 0	100% +11.11	84.55% -2.28
Bearish	—	0% 0	0% -11.11	15.45% +2.28

Bullish· Mar 4

$CDIO has broken intraday resistance at $5.00 with increasing volume, setting a target of $5.30-$5.55.
The asset has shown a slow but steady climb, bouncing back to $8 and potentially reaching $50+ in the long term.
After a recent flush, buyers have stepped in, and the structure is now showing higher lows, indicating a possible return of fast money if the breakdown area is reclaimed.

Bearish· Mar 13

The company's revenue has flatlined, with some even suggesting that the business is "terminal".
The company's management team is seen as AWOL, with some suggesting that this has contributed to the stock's decline.
The company's decision to delay reporting losses is seen as a negative sign, with some predicting that the stock will fall to $2 or lower.

Generated by AI

Topics

Of the messages about CDIO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	82.61%	42.42%
Technical Analysis	—	0%	0%	55.72%
Controversies	—	0%	17.39%	0.67%
Analysts	—	0%	0%	0%
Earnings	—	0%	0%	1.18%
Macro	—	0%	0%	0%

Announcements· Jul 16

Cardio Diagnostics Holdings, Inc. (CDIO) is poised at the intersection of AI and precision medicine, with its technology potentially revolutionizing the healthcare industry.
The company's focus on AI and precision medicine may lead to significant advancements in medical diagnosis and treatment, making it an exciting development in the healthcare sector.
Cardio Diagnostics Holdings, Inc. (CDIO) is gaining attention for its innovative approach to healthcare, with its AI and precision medicine technology expected to make a substantial impact on the industry.

Technical Analysis· Feb 24

$CDIO has shown a strong run into the $3.80s, followed by a tight pennant consolidation near $3.45, with a higher low holding above the prior breakout.
The stock has a breakout at $3.63 with a stop at $3.38, looking for a push to $4.00+ with a risk-reward ratio of 2.4 and 253x relative volume.
$CDIO has a strong buy signal from a technical analysis perspective, with moving averages and other indicators suggesting a strong buy.

Generated by AI

Community

Of the messages about CDIO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	93.33%	68.42%	38.13%
Newcomers	—	6.67%	31.58%	61.87%

Regulars· Jul 16

The company's stock, $CDIO, is poised at the intersection of AI and precision medicine, according to recent news breaks, which highlight its potential for growth in the healthcare sector.
Cardio Diagnostics Holdings, Inc. is making progress toward profitability, as evidenced by its record second quarter performance, according to NextBoat's update.
Oncolytics Biotech's FDA milestone is seen as a significant development for the industry, and its impact on $CDIO and other healthcare stocks is being closely watched by regular participants.

Newcomers· May 15

The intersection of precision medicine and preventive care is a key factor in Cardio Diagnostics Holdings, Inc.'s ($CDIO) growth potential.
New investors are taking advice from others on momentum stocks, including $CDIO, and are seeing positive results.
$CDIO is being touted as a poised stock at the intersection of precision medicine and preventive care, with potential for future growth.

Generated by AI

News

Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

CHICAGO, August 26, 2026--Cardio Diagnostics has released a new edition of the company’s rural health report: The State of Rural Hospitals and Cardiovascular Care.

1mo agoYahoo Finance

Cardio Diagnostics launches CLIA-certified laboratory in Iowa

1mo agoInvesting.com

Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City

CHICAGO, August 18, 2026--Cardio Diagnostics launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa.

1mo agoYahoo Finance

Also Discussed

Investors talking about CDIO also mention

#	Name	Attention
1	HeartSciences Inc.HSCS	0%0
2	PaxMedica Inc.PXMD	0%0
3	Naya Biosciences Inc.INVO	0%0
4	Apollomics Inc.APLM	0%0
5	Tenon Medical, Inc.TNON	0%new
6	ParaZero Technologies Ltd.PRZO	0%+0
7	ZVSA - ZyVersa Therapeutics, Inc.	——
8	AWIN - AERWINS Technologies Inc.	——
9	Tempest Therapeutics Inc.TPST	0%+0
10	Dermata Therapeutics, Inc.DRMA	0%new

Cardio Diagnostics Holdings, Inc.

Healthcare
Biotechnology

Cardio Diagnostics Holdings, Inc. is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular disease. The company’s current offerings include blood-based diagnostics for coronary heart disease risk assessment and early detection, supported by AI-driven analysis of genetic and epigenetic biomarkers. Cardio Diagnostics also provides tools and platforms that help clinicians interpret cardiovascular risk and support research and development use in biopharmaceutical and medical settings. Its products are designed to improve the assessment, detection, and management of cardiovascular conditions such as coronary heart disease and related comorbidities through more precise clinical insights. Based in Chicago, Illinois, Cardio Diagnostics Holdings serves the growing market for advanced cardiovascular diagnostics and precision medicine.

Website

Location

311 West Superior Street

Chicago, IL, 60654

United States

Social

What share of all stock conversation is about CDIO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% -0.01

Jul 16

Cardio Diagnostics Holdings, Inc. (CDIO) is positioned at the intersection of AI and precision medicine, potentially offering significant opportunities in the healthcare sector.
CDIO's focus on AI and precision medicine may enable it to improve healthcare outcomes, making it an attractive investment for those interested in the intersection of technology and healthcare.
The company's unique approach to combining AI with precision medicine could lead to breakthroughs in medical diagnosis and treatment, driving growth and innovation in the healthcare industry.

Generated by AI

Sentiment

Of the messages about CDIO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% 0	100% +11.11	84.55% -2.28
Bearish	—	0% 0	0% -11.11	15.45% +2.28

Bullish· Mar 4

$CDIO has broken intraday resistance at $5.00 with increasing volume, setting a target of $5.30-$5.55.
The asset has shown a slow but steady climb, bouncing back to $8 and potentially reaching $50+ in the long term.
After a recent flush, buyers have stepped in, and the structure is now showing higher lows, indicating a possible return of fast money if the breakdown area is reclaimed.

Bearish· Mar 13

The company's revenue has flatlined, with some even suggesting that the business is "terminal".
The company's management team is seen as AWOL, with some suggesting that this has contributed to the stock's decline.
The company's decision to delay reporting losses is seen as a negative sign, with some predicting that the stock will fall to $2 or lower.

Generated by AI

Topics

Of the messages about CDIO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	82.61%	42.42%
Technical Analysis	—	0%	0%	55.72%
Controversies	—	0%	17.39%	0.67%
Analysts	—	0%	0%	0%
Earnings	—	0%	0%	1.18%
Macro	—	0%	0%	0%

Announcements· Jul 16

Cardio Diagnostics Holdings, Inc. (CDIO) is poised at the intersection of AI and precision medicine, with its technology potentially revolutionizing the healthcare industry.
The company's focus on AI and precision medicine may lead to significant advancements in medical diagnosis and treatment, making it an exciting development in the healthcare sector.
Cardio Diagnostics Holdings, Inc. (CDIO) is gaining attention for its innovative approach to healthcare, with its AI and precision medicine technology expected to make a substantial impact on the industry.

Technical Analysis· Feb 24

$CDIO has shown a strong run into the $3.80s, followed by a tight pennant consolidation near $3.45, with a higher low holding above the prior breakout.
The stock has a breakout at $3.63 with a stop at $3.38, looking for a push to $4.00+ with a risk-reward ratio of 2.4 and 253x relative volume.
$CDIO has a strong buy signal from a technical analysis perspective, with moving averages and other indicators suggesting a strong buy.

Generated by AI

Community

Of the messages about CDIO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	93.33%	68.42%	38.13%
Newcomers	—	6.67%	31.58%	61.87%

Regulars· Jul 16

The company's stock, $CDIO, is poised at the intersection of AI and precision medicine, according to recent news breaks, which highlight its potential for growth in the healthcare sector.
Cardio Diagnostics Holdings, Inc. is making progress toward profitability, as evidenced by its record second quarter performance, according to NextBoat's update.
Oncolytics Biotech's FDA milestone is seen as a significant development for the industry, and its impact on $CDIO and other healthcare stocks is being closely watched by regular participants.

Newcomers· May 15

The intersection of precision medicine and preventive care is a key factor in Cardio Diagnostics Holdings, Inc.'s ($CDIO) growth potential.
New investors are taking advice from others on momentum stocks, including $CDIO, and are seeing positive results.
$CDIO is being touted as a poised stock at the intersection of precision medicine and preventive care, with potential for future growth.

Generated by AI

Cardio Diagnostics Holdings

Social

Jul 16

Bullish· Mar 4

Bearish· Mar 13

Announcements· Jul 16

Technical Analysis· Feb 24

Regulars· Jul 16

Newcomers· May 15

Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

Cardio Diagnostics launches CLIA-certified laboratory in Iowa

Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City

Also Discussed

Cardio Diagnostics Holdings, Inc.

Company Information

Location

Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

Cardio Diagnostics launches CLIA-certified laboratory in Iowa

Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City

Also Discussed

Social

Jul 16

Bullish· Mar 4

Bearish· Mar 13

Announcements· Jul 16

Technical Analysis· Feb 24

Regulars· Jul 16

Newcomers· May 15